Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000727215 | SCV000706665 | pathogenic | not provided | 2017-02-27 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002502424 | SCV002787399 | likely pathogenic | Polycystic kidney disease 4 | 2024-05-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000409814 | SCV003501100 | pathogenic | Autosomal recessive polycystic kidney disease | 2024-01-04 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Val1232Asnfs*8) in the PKHD1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PKHD1 are known to be pathogenic (PMID: 19940839). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PKHD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 370781). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV002502424 | SCV004204688 | likely pathogenic | Polycystic kidney disease 4 | 2024-03-23 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000409814 | SCV000486184 | likely pathogenic | Autosomal recessive polycystic kidney disease | 2016-04-12 | no assertion criteria provided | clinical testing |